Dana Brown: So you’re tracking right along with it. So we are going through an exercise right now to refine, actually our budget for FY ’24, so that we can get that approved by our Board at the upcoming December meeting. But there are really 2 areas that we’re looking at for investment. So we’ve got, I’ll say, spent the money right or have any commitments out there but it is what we’re looking at so that we can determine what the ROI would be. The first one is on the sales team side. So how can we do some restructuring of the current sales team to get them better focused on new business versus ongoing account management. So I talked a little bit about that. We believe that we have a significant amount of kind of lapsed revenue.
Just have had team members on top of ensuring that accounts stay current on their maintenance support agreements if they had purchased a perpetual license. So kind of getting more of an account management focus to some members of the team and then bringing on some additional team members focused on new business. And then, the second area that we’re looking at is regulatory. So we’re in a fortunate position now of having multiple products that have been developed over the last 2 years and multiple versions of those products and then the work with Google as well. So we need to figure out how we can enable our regulatory team to work in parallel through multiple approval processes instead of being very sequential. So that way, we can begin to commercialize solutions in markets faster.
So those are the 2 areas that we’re looking at. So I think to your point, you probably will see a bit of an uptick in spend but — we’re going to continue to be really conservative and cautious to use the phrase, not get out in front of our skis in that regard but there will be a little bit there.
Per Ostlund: Okay. That’s more than reasonable. Actually, I’m going to come back to my first question just because a question was lengthy. Now that you have the detection business as really that’s the singular focus and the cost structure is mostly, I think, set at this point. Is there a breakeven revenue level in mind, whether it’s on an EBITDA basis or a cash flow basis? Or is it too early to say?
Eric Lonnqvist: I think it’s — all the initiatives in introspection. I mean you could look at the EBITDA that we released for this quarter and just minus 1.1% and say if we had that much more in sales, it would be breakeven. But I don’t know that the cost structure is completely solidified yet. There’s a lot we’re looking at.
Per Ostlund: Okay. That’s fair. All right. I’ll let some other people ask some questions. Thanks.
Operator: [Operator Instructions] That concludes our Q&A session. I will now hand the conference back to Dana Brown, President and Chief Executive Officer, for closing remarks. Please go ahead.
Dana Brown: Thank you, operator. In conclusion, we’re making bold moves to rapidly transform this company with a focus on maintaining stability, preserving cash and building a defensible and competitive long-term strategy that diversifies our revenue stream and smooth out that customer concentration. Demand for our technology continues to be strong and the evidence supporting it continues to grow and our team continues to secure opportunities with some of the most prestigious and esteemed health care facilities worldwide. I remain optimistic about the company and its future and I firmly believe in the bright future of the company and our ability to generate significant shareholder value. Thank you and have a great evening.
Operator: Thank you, everyone. This concludes today’s event. You may disconnect at this time and have a wonderful day. Thank you for your participation.
